EUVIMEDEUVIMED entdecken
Crossref

EBV and CMV Seroprevalence and Liver Injury Patterns Among Clinical Patients in Beijing: Differential Impact of Immunosuppression Status

Zhaoxiang Du iD, Xingxing Yuan, Jie Yi iD, Manyu Li, Fangfang Dai, Xin Liu, Ning Liu iD, Haiqing Sun, Lili Zhang, Yanhua Yu

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.70837 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Zhaoxiang Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Center, Beijing Youan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Immunocompromised Host, Epstein-Barr Virus Infections, Liver Diseases. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Beijing Natural Science Foundation-Daxing Innovation Joint Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non‐hepatotropic viruses (NHVs), as a category of pathogens not primarily targeting the liver, can also cause hepatic injury. Liver injury associated with Epstein‐Barr virus (EBV) and cytomegalovirus (CMV) infections, in particular, often attracts significant clinical attention. This retrospective cohort study analyzed the seroprevalence and clinical features of EBV and CMV infections among patients in Beijing from 2020 to 2024, with a focus on the impact of immunosuppression status on liver injury patterns. The CMV IgM positivity rate was 4.00% (646/16,201), and the EBV IgM positivity rate was 7.84% (1007/12,838), both showing significant upward annual trends ( p < 0.001). Analysis of 236 IgM‐positive inpatients revealed a “bifurcation phenomenon”: the non‐immunosuppressed group exhibited more severe hepatocellular injury (e.g., ALT levels 6.5‐ to 10.9‐fold higher) and cholestatic damage (e.g., CMV group: TBIL increased 7.8‐fold), yet had better clinical outcomes (adverse outcome rate: 0–4.8%) compared to the immunosuppressed group (adverse outcome rate: 18.4–27.8%, p < 0.05). Further analysis of 125 patients with confirmed liver injury demonstrated that the immunosuppressed group had severe CD4 + T‐cell depletion and inverted CD4 + /CD8+ ratios. During EBV and CMV co‐infection, the immunosuppressed group showed higher CMV DNA detection rates (66.7% vs. 20.0%, p = 0.0097) and viral loads (median 2675 vs. 625 copies/mL, p = 0.002). Within the immunosuppressed group, patients with CD4 + T‐cell counts > 300 cells/μL had higher ALT and AST levels, supporting an immune‐mediated injury mechanism. These findings indicate that immune status and virus type jointly shape the clinical spectrum of EBV/CMV‐related liver injury. The dissociation between severe liver injury and favorable prognosis in non‐immunosuppressed patients underscores the role of immune pathology, while poorer outcomes in immunosuppressed patients are driven by CD4 + T‐cell depletion, impaired viral clearance, and extrahepatic complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsImmunocompromised HostEpstein-Barr Virus InfectionsLiver DiseasesSeroepidemiologic StudiesHerpesvirus 4, HumanPrevalenceCytomegalovirusBeijingRetrospective StudiesImmunoglobulin MAntibodies, ViralHumansMaleFemaleYoung AdultAdultMiddle AgedAged

Substanzen

Immunoglobulin MAntibodies, Viral

Autor:innen und Institutionen

  • Department of Clinical Laboratory Center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
  • Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Division I of In Vitro Diagnostics for Infectious Diseases, Institute for In Vitro Diagnostics Control, National Institutes for Food and Drug Control, Beijing, China.

ORCID-Profile: Zhaoxiang Du, Jie Yi, Ning Liu

Förderung

  • Beijing Natural Science Foundation-Daxing Innovation Joint Fund

Zitieren

APA

Du, Z., Yuan, X., Yi, J., Li, M., Dai, F., Liu, X., Liu, N., Sun, H., Zhang, L., & Yu, Y. (2026). EBV and CMV Seroprevalence and Liver Injury Patterns Among Clinical Patients in Beijing: Differential Impact of Immunosuppression Status. Journal of Medical Virology. https://doi.org/10.1002/jmv.70837

Vancouver

Du Z, Yuan X, Yi J, Li M, Dai F, Liu X, et al. EBV and CMV Seroprevalence and Liver Injury Patterns Among Clinical Patients in Beijing: Differential Impact of Immunosuppression Status. Journal of Medical Virology. 2026. doi:10.1002/jmv.70837

BibTeX
@article{Du2026,
  author = {Du, Zhaoxiang and Yuan, Xingxing and Yi, Jie and Li, Manyu and Dai, Fangfang and Liu, Xin and Liu, Ning and Sun, Haiqing and Zhang, Lili and Yu, Yanhua},
  title = {EBV and CMV Seroprevalence and Liver Injury Patterns Among Clinical Patients in Beijing: Differential Impact of Immunosuppression Status},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.70837}
}
Kostenlos starten →